SCHEMBL5582020

SCHEMBL5582020

CCOc1c(Br)cc(-c2cccc(Cl)c2)c2cnc(NC)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 6/20 0.40
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
CSNK2A1 P68400 1/20 0.37
MAP4K4 O95819 2/20 0.36
EGFR P00533 1/20 0.35
DHFR P00374 1/20 0.34
NUDT1 P36639 1/20 0.34
LIMK1 P53667 1/20 0.34
TP53 P04637 2/20 0.34
POLB P06746 2/20 0.34
MAPT P10636 2/20 0.34
BRD4 O60885 1/20 0.34
BLM P54132 1/20 0.34
SCN9A Q15858 1/20 0.34
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
SIK1 P57059 1/20 0.33
SIK2 Q9H0K1 1/20 0.33
SIK3 Q9Y2K2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582085 0.89 CSNK2A2 (0.38) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4
SCHEMBL5581986 0.86 CSNK2A2 (0.36) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4
SCHEMBL5582153 0.83 CSNK2A2 (0.41) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4
SCHEMBL5582009 0.82 ADORA1 (0.41) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4
SCHEMBL5582194 0.81 CSNK2A1 (0.48) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4
SCHEMBL5581799 0.79 FYN (0.41) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4
SCHEMBL5581820 0.79 ADORA1 (0.43) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4
SCHEMBL5581817 0.78 CSNK2A2 (0.41) ADORA1CSNK2A2CSNK2BCSNK2A1DHFR
SCHEMBL5581883 0.78 ADORA1 (0.41) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4
SCHEMBL5582125 0.78 ADORA1 (0.38) ADORA1CSNK2A2CSNK2BCSNK2A1MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225308-A1 2-Amino Quinazoline Derivative KYOWA HAKKO KOGYO CO.,LTD. (JP) 2007-09-27 US disclosed
EP-1726584-A1 2-AMINOQUINAZOLINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225308-A1 2-Amino Quinazoline Derivative AGTR2, ABL1, AGTR1 ADORA1 406/4885CSNK2A2 467/4885CSNK2B 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.